Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 601–700 of 1,004
NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness
Wu, X., & Williams, K. J. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244525 · Cited by 67
“phosphorylation of GSK3 is barely blunted(41) and mTORC1 exhibits enhanced activity.(42,43) In addition, SEIRR leaves the”
BackgroundGbb/BMP signaling is required to maintain energy homeostasis in Drosophila
Ballard, S. L., Jarolimova, J., & Wharton, K. A. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.11.011 · Cited by 73
“TOR kinase activity is influenced by amino acid availability, and decreases in TOR function have been shown to result in reduced lipid stores in both Drosophila and vertebrates (Gao et al., 2002; Hara et al., 1998; Luong et al., 2006; Radimerski et al., 2002; Stocker et al., 2003; Um et al., 2004).”
BackgroundMCH−/− Mice Are Resistant to Aging-Associated Increases in Body Weight and Insulin Resistance
Jeon, J. Y., Bradley, R. L., Kokkotou, E. G., Marino, F. E., Wang, X., Pissios, P., & Maratos-Flier, E. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0203 · Cited by 65
Hot topics in aging research: protein translation and TOR signaling, 2010
Kaeberlein, M., & Kennedy, B. K. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00665.x · Cited by 66
“Adipose-specific knockout of the TORC1 component raptor results in resistance to diet-induced obesity, as does whole-body knockout of S6K1 (Um et al., 2004; Polak et al., 2008).”
BackgroundEvaluation of off-label rapamycin use to promote healthspan in 333 adults
Kaeberlein, T. L., Green, A. S., Haddad, G., Hudson, J., Isman, A., Nyquist, A., Rosen, B. S., Suh, Y., Zalzala, S., Zhang, X., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00818-1 · Cited by 70
Nutrition in early life, immune-programming and allergies: the role of epigenetics.
Amarasekera, M., Prescott, S. L., & Palmer, D. J. (2013) · PubMed · Cited by 80
Blagosklonny, M. V. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0722 · Cited by 67
“40 Also, hyperactive TOR decreases the PDGF receptor (PDGF-R) expression, rendering cells irresponsive to PDGF.”
Effect of TRB3 on Insulin and Nutrient-stimulated Hepatic p70 S6 Kinase Activity
Matsushima, R., Harada, N., Webster, N. J. G., Tsutsumi, Y. M., & Nakaya, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511636200 · Cited by 77
Patel, S. A., Hoehn, K. L., Lawrence, R. T., Sawbridge, L., Talbot, N. A., Tomsig, J. L., Turner, N., Cooney, G. J., Whitehead, J. P., Kraegen, E. W., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1368 · Cited by 66
Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
Hernández, M. G., García-Aguilar, A., Burillo, J., Gómez, R., Manca, M. A., Novials, A., Alcarraz‐Vizán, G., Guillén, C., & Benito, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0533-x · Cited by 70
Autophagy Dysregulation and Obesity-Associated Pathologies.
Namkoong, S., Cho, C., Semple, I. A., & Lee, J. H. (2018) · PubMed Central · doi:10.14348/molcells.2018.2213 · Cited by 72
“Indeed, mTORC1 activity is chronically upregulated during obesity, which is associated with increased anabolic metabolism in liver (Dann et al., 2007; Um et al., 2004).”
BackgroundGinion, A., Auquier, J., Benton, C. R., Mouton, C., Vanoverschelde, J.-L., Hue, L., Horman, S., Beauloye, C., & Bertrand, L. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2010 · Cited by 64
“This is reenforced by the fact that the deletion of p70S6K in mice protects against diet-induced obesity and enhances insulin sensitivity (37).”
BackgroundAKT-dependent and -independent pathways mediate PTEN deletion-induced CNS axon regeneration
Huang, H., Miao, L., Yang, L., Liang, F., Qizhao, W., Zhuang, P., Sun, Y., & Hu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1289-z · Cited by 68
Protein turnover in cardiac cell growth and survival
Hedhli, N., Pelat, M., & Depre, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.025 · Cited by 67
“This mechanism of regulation explains why a deletion of S6K1 increases insulin sensitivity [25].”
BackgroundAmino Acid Regulation of Autophagosome Formation
Meijer, A. J. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_5 · Cited by 62
Ghrelin-induced food intake and adiposity depend on central mTORC1/S6K1 signaling
Stevanović, D., Trajković, V., Müller-Lühlhoff, S., Brandt, E., Abplanalp, W. A., Bumke‐Vogt, C., Liehl, B., Wiedmer, P., Janjetović, K., Starcevic, V. P., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.009 · Cited by 67
“Consistent with this hypothesis, higher energy expenditure has been reported in these mice even when fed a high-fat diet (Um et al., 2004; Castañeda et al., 2012).”
BackgroundGoh, E. T. H., Pardo, O. E., Michael, N., Niewiarowski, A., Totty, N., Volkova, D., Tsaneva, I. R., Seckl, M. J., & Gout, I. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078782 · Cited by 70
Alliouachene, S., Tuttle, R. L., Boumard, S., Lapointe, T., Bérissi, S., Germain, S., Jaubert, F., Tosh, D., Birnbaum, M. J., & Pende, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35237 · Cited by 69
Amino acid transporters in the regulation of insulin secretion and signalling
Javed, K., & Fairweather, S. J. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180250 · Cited by 68
Guo, S., Dunn, S. L., & White, M. F. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0092 · Cited by 72
“The mTOR cascade can directly stimulate Irs protein phosphorylation through down stream effectors like the S6K (45, 46).”
BackgroundInfluentialTsai, S.-Y., Rodriguez, A. A., Dastidar, S. G., Del Greco, E., Carr, K. L., Sitzmann, J. M., Academia, E. C., Viray, C. M., Martinez, L. L., Kaplowitz, B. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.029 · Cited by 63
“Reduced mTORC1 activity has been reported to prevent development of T2D and protect against diabetic nephropathy in both type I and type II diabetic mouse models (Godel et al., 2011; Inoki et al., 2011; Polak et al., 2008; Um et al., 2004; Yang et al., 2007).”
BackgroundBesse‐Patin, A., & Estall, J. L. (2014) · International Journal of Cell Biology · doi:10.1155/2014/519153 · Cited by 71
Mark, P. J., Sisala, C., Connor, K., Patel, R., Lewis, J. L., Vickers, M. H., Waddell, B. J., & Sloboda, D. M. (2011) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000681 · Cited by 62
“The mammalian target of rapamycin (mTOR) is a wellconserved serine/threonine protein kinase that functions as an intracellular nutrient sensor and has been implicated in the pathogenesis of obesity and other related metabolic disorders.(22,23) Placental mTOR has been suggested to regulate *Address for correspondence:…”
BackgroundLiu, X., Yuan, H., Niu, Y., Niu, W., & Fu, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.07.008 · Cited by 241
Han, B., Zhu, M. J., Ma, C., & Du, . (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-102 · Cited by 67
The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity
Lamri, A., Pigeyre, M., Garver, W. S., & Meyre, D. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00176 · Cited by 67
Di, R., Wu, X., Chang, Z., Zhao, X., Feng, Q., Lu, S., Luan, Q., Hemmings, B. A., Li, X., & Yang, Z. (2011) · Biochemical Journal · doi:10.1042/bj20110033 · Cited by 68
Brummer, T., Schmitz‐Peiffer, C., & Daly, R. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07865.x · Cited by 75
Moghei, M., Tavajohi‐Fini, P., Beatty, B., & Adegoke, O. A. J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00062.2016 · Cited by 69
“Furthermore, as for leucine (14, 27, 46), our inhibition studies implicated mTORC1 in the KIC-induced suppression of insulin-stimulated glucose transport.”
BackgroundAKT and cancer—Is it all mTOR?
Rosen, N., & She, Q. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.001 · Cited by 66
Song, X., Shen, Q., Fan, L., Yu, Q., Jia, X., Sun, Y., Bai, W., & Kang, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24190 · Cited by 59
“In the liver and skeletal muscle of obese and high-fat-fed rodents, mTORC1 is highly active [24, 25].”
BackgroundThe combination of loss of glyoxalase1 and obesity results in hyperglycemia
Lodd, E., Wiggenhauser, L. M., Morgenstern, J., Fleming, T. H., Poschet, G., Büttner, M., Tabler, C. T., Wohlfart, D. P., Nawroth, P. P., & Krøll, J. (2019) · JCI Insight · doi:10.1172/jci.insight.126154 · Cited by 61
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
mTOR in health and in sickness
Liko, D., & Hall, M. N. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1326-7 · Cited by 67
“S6K1 by mTORC1 elicits a negative feedback loop as phospho-S6K1 disrupts signaling directly downstream of RTKs, ultimately reducing mTORC1 activity [55–57].”
mTORC1 Activation Requires DRAM-1 by Facilitating Lysosomal Amino Acid Efflux
Beaumatin, F., O’Prey, J., Barthet, V. J. A., Zunino, B., Parvy, J.-P., Bachmann, A., O’Prey, M., Kania, E., Gonzalez, P. S., Macintosh, R. L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.021 · Cited by 68
“DRAM-1 Controls Insulin Signaling Changes in mTORC1 activity can have a negative impact on insulin signaling, because mTORC1 signaling drives negative feedback on insulin receptor substrate 1 (IRS-1) through inhibitory phosphorylation (Harrington et al., 2004; Tremblay and Marette, 2001; Um et al., 2004).”
BackgroundCao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N., & Nakae, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608116200 · Cited by 66
Signaling crosstalk between the mTOR complexes
Xie, J., & Proud, C. G. (2014) · Translation · doi:10.4161/trla.28174 · Cited by 59
“2A).(93) Since then, many additional IRS1 phosphorylation sites have been discovered which negatively affect IRS1 function.”
BackgroundRivas, D. A., Yaspelkis, B. B., Hawley, J. A., & Lessard, S. J. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0202 · Cited by 67
“In contrast, S6K1 null mice are protected from HF diet-induced insulin resistance (Um et al. 2004).”
Wullschleger, S., Wasserman, D. H., Gray, A., Sakamoto, K., & Alessi, D. R. (2011) · Biochemical Journal · doi:10.1042/bj20102012 · Cited by 64
“For example, overactivation of the mTORC1 pathway as a result of obesity induces insulin resistance by stimulating phosphorylation and degradation of IRS (insulin receptor substrate) adaptor proteins required for activation of PI3K by insulin [8].”
BackgroundIs REDD1 a Metabolic Éminence Grise ?
Lipina, C., & Hundal, H. S. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.08.005 · Cited by 64
Hartogh, D. J. D., Vlavcheski, F., Giacca, A., & Tsiani, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144900 · Cited by 64
“Additionally, in p70 S6K-deficient mice, the ser307 and ser636/639 phosphorylation of IRS-1, induced by a high fat diet, was noticeably reduced, indicating that p70 6SK might be involved in the induction of insulin resistance [49].”
BackgroundResultSignaling Pathways: The Benefits of Good Communication
Fisher, T. L., & White, M. F. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.024 · Cited by 60
“Can hyperactivation of the mTOR/S6K cascade contribute to systemic insulin resistance? A recent analysis [13] of S6K1–/– mice supports the view that S6K1 has an important role in the inhibition of IRS1 signaling by diet or obesity.”
BackgroundInfluentialSystem-L amino acid transporters play a key role in pancreatic β-cell signalling and function
Cheng, Q., Beltran, V. D., Chan, S. M. H., Brown, J. R. G., Bevington, A., & Herbert, T. P. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0212 · Cited by 65
Rapamycin-Induced Glucose Intolerance: Hunger or Starvation Diabetes
Blagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18595 · Cited by 59
Crosstalk between mTOR complexes
Xie, J., & Proud, C. G. (2013) · Nature Cell Biology · doi:10.1038/ncb2877 · Cited by 66
McCall, K. D., Holliday, D. K., Dickerson, E., Wallace, B., Schwartz, A. L., Schwartz, C., Lewis, C. J., Kohn, L. D., & Schwartz, F. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0370 · Cited by 64
“2002, Um et al .”
Melnik, B. C. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150114100653 · Cited by 63
“Excessive amounts of circulating BCAAs activate mTORC1 and its downstream substrate, the kinase S6K1 [23,33,165,166], which reduces insulin signaling by inhibitory phosphoryla- tion of IRS-1 [165-174].”
BackgroundInfluentialProulx, K., Cota, D., Woods, S. C., & Seeley, R. J. (2008) · Diabetes · doi:10.2337/db07-1690 · Cited by 63
“059) and the interaction between drug and diet (F(1,26) 3.”
BackgroundMelnik, B. C., John, S. M., & Schmitz, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-014-0377-9 · Cited by 65
“Overactivated S6K1 via phosphorylation of insulin receptor substrate-1 (IRS-1) is a pivotal mechanism that induces insulin resistance [74,75].”
BackgroundNutrient Excess in AMPK Downregulation and Insulin Resistance.
Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2013) · PubMed · Cited by 78
PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals
Ha, S. H., Kim, D., Kim, I.-S., Kim, J. H., Lee, M. N., Lee, H. J., Jong Heon, K. I. M., Jang, S. K., Suh, P., & Ryu, S. H. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.05.021 · Cited by 63
Mechanisms of resistance to mTOR inhibitors
Formisano, L., Napolitano, F., Rosa, R., D’Amato, V., Servetto, A., Marciano, R., De Placido, P., Bianco, C., & Bianco, R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102886 · Cited by 59
da Rocha, A. L., Pereira, B. C., Pauli, J. R., de Souza, C. T., Teixeira, G. R., Lira, F. S., Cintra, D. E., Ropelle, E. R., Júnior, C. R. B., & da Silva, A. S. R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25197 · Cited by 60
“However, some inhibitory sites of the insulin receptor substrate-1 (IRS-1; Ser307/636/639) for mTOR and S6K1 function as a feedback inhibition loop, when this hypertrophy pathway is overactivated (Um et al., 2004; Tzatsos and Kandror, 2006).”
BackgroundSummermatter, S., Mainieri, D., Russell, A. P., Seydoux, J., Montani, J. P., Buchala, A., Solinas, G., & Dulloo, A. G. (2008) · The FASEB Journal · doi:10.1096/fj.07-8972com · Cited by 57
Role of autophagy in β ‐cell function and mass
Hur, K. Y., Jung, H. S., & Lee, M. ‐. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01278.x · Cited by 57
“For example, reconciliation of such increased number of autophagosomes in obesity with previous results showing increased activation of mTOR, an inhibitor of autophagy, in tissues of obese mice [36] could be an intriguing issue.”
ResultMammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications
Lieberthal, W., & Levine, J. S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00015.2012 · Cited by 57
Early responses of insulin signaling to high-carbohydrate and high-fat overfeeding
Adochio, R., Leitner, J. W., Gray, K., Draznin, B., & Cornier, M. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-37 · Cited by 65
“Ability of S6K1 to promote serine phosphorylation of IRS-1 has been suggested as a potential mechanism of insulin resistance [30-37,53,54].”
BackgroundShum, M., Bellmann, K., St‐Pierre, P., & Marette, A. (2016) · Diabetologia · doi:10.1007/s00125-015-3839-6 · Cited by 64
“Um et al [12] first showed that S6K1 mice are protected against diet-induced obesity and insulin resistance, and this was associated with increased Akt S473 phosphorylation in insulin target tissues.”
BackgroundSims‐Robinson, C., Bakeman, A., Bruno, E. S., Jackson, S., Glasser, R., Murphy, G. G., & Feldman, E. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163883 · Cited by 63
Chimin, P., Andrade, M. L., Belchior, T., Paschoal, V. A., Magdalon, J., Yamashita, A. S., Castro, É., Castoldi, Â., Chaves‐Filho, A. B., Yoshinaga, M. Y., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074518 · Cited by 67
“Obesity, through unknown mechanisms, is also associated with a chronic activation of mechanistic target of rapamycin complex (mTORC)1 in adipose tissue (7).”
BackgroundZhang, X., Wu, D., Wang, C., Luo, Y., Ding, X., Yang, X., Silva, F. D., Arenas, S., Weaver, J. M., Mandell, M. A., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1703355 · Cited by 60
“Previous studies show that inhibition of MTORC1 by fabp4driven ablation of RPS6KB or RPTOR enhances thermogenesis and energy expenditure, leading to protection against dietinduced obesity and glucose intolerance [21,32].”
BackgroundRapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs
Aggarwal, D., Fernández, M. L., & Soliman, G. A. (2006) · Metabolism · doi:10.1016/j.metabol.2006.01.017 · Cited by 65
“Similarly, Um et al [38] reported the presence of elevated FFA with high fat feeding in mice lacking S6K-1, the downstream effector of mTOR.”
BackgroundFernández‐Veledo, S., Vázquez‐Carballo, A., Vila‐Bedmar, R., Ceperuelo‐Mallafré, V., & Vendrell, J. J. (2013) · IUBMB Life · doi:10.1002/iub.1170 · Cited by 62
“Downstream of mTORC1 signaling pathway, deletion of p70S6K protects against age- and diet-induced obesity, and genetic models of obesity exhibit markedly increased p70S6K activity (62).”
BackgroundChapter 13 Phosphorylation of IRS Proteins
Sun, X., & Liu, F. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00613-4 · Cited by 73
Melnik, B. C. (2012) · Journal of Obesity · doi:10.1155/2012/197653 · Cited by 63
“The importance of mTORC1-S6K1 signalling in adipogenesis becomes apparent in S6K1-deficient mice, which are protected against ageand diet-induced obesity while enhancing insulin sensitivity [88].”
BackgroundSarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents
Bollheimer, L. C., Buettner, R., Pongratz, G., Brunner-Ploss, R., Hechtl, C., Banas, M., Singler, K., Hamer, O. W., Stroszczynski, C., Sieber, C. C., et al. (2012) · Biogerontology · doi:10.1007/s10522-012-9405-4 · Cited by 59
“Therefore, a dietand probably also age-induced downregulation of S6K1 might be a compensatory and protective mechanism against insulin-resistance (Um et al. 2004) while it promotes sarcopenia.”
BackgroundTuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
Cao, J., Tyburczy, M. E., Moss, J., Darling, T. N., Widlund, H. R., & Kwiatkowski, D. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84262 · Cited by 58
Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration
Nguyen, J. T., Ray, C., Fox, A. L., Mendonça, D. B. S., Kim, J. K., & Krebsbach, P. H. (2018) · Science Advances · doi:10.1126/sciadv.aao5838 · Cited by 59
Kim, Y. K., Choi, H., Kim, N. H., Lee, W., Seo, D. W., Kang, D. W., Lee, H. Y., Han, J., Park, S. W., & Kim, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.165 · Cited by 60
Gaumann, A. K. A., Schlitt, H. J., & Geissler, E. K. (2008) · Transplant International · doi:10.1111/j.1432-2277.2007.00610.x · Cited by 59
“This negative regulatory loop could explain the relative benign nature of tumors associated with TSC mutations, and also may provide a means for tumor resistance to mTOR inhibition [52] (Fig.”
BackgroundMalik, A. R., Urbańska, M., Macias, M., Skalecka, A., & Jaworski, J. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.12.010 · Cited by 66
Kim, S., Jang, Y., Chau, G. C., Pyo, S., & Um, S. H. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.161 · Cited by 61
Self-citationWang, T., Kusudo, T., Takeuchi, T., Yamashita, Y., Kontani, Y., Okamatsu‐Ogura, Y., Saito, M., Mori, N., & Yamashita, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083264 · Cited by 232
“The recent advance in understanding the role of the mTORS6K signaling pathway is of great interest in relation to the effects of evodiamine, because this signaling pathway is activated in response to growth factors, insulin or nutrients such as glucose and amino acids [12,14] and its increased activity leads to serine…”
BackgroundProtein Anabolic Responses to a Fed Steady State in Healthy Aging
Chevalier, S., Goulet, E. D. B., Burgos, S. A., Wykes, L. J., & Morais, J. A. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr036 · Cited by 53
“Signaling downstream of mTOR was evaluated by the phosphorylation of two targets of S6K1, rpS6, and IRS-1 and of 4E-BP1.”
BackgroundInfluentialSun, L., Yu, Y., Hu, W., Min, Q., Kang, H., Li, Y., Hong, Y., Wang, X., & Hong, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.009 · Cited by 61
Mazelin, L., Panthu, B., Nicot, A.-S., Belotti, E., Tintignac, L. A. J., Teixeira, G., Zhang, Q., Risson, V., Baas, D., Delaune, E. A., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.04.011 · Cited by 56
The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity
Conn, C. S., Yang, H., Tom, H. J., Ikeda, K., Osés-Prieto, J. A., Vu, H., Oguri, Y., Nair, S., Gill, R. M., Kajimura, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00349-z · Cited by 58
Fang, C. X., Dong, F., Ren, B. H., Epstein, P. N., & Ren, J. T. (2005) · Diabetologia · doi:10.1007/s00125-005-1940-y · Cited by 57
“Several post-receptor components, including the serine/threonine protein kinase Akt, protein tyrosine phosphatase 1B (PTP1B), peroxisome proliferator-activated receptor γ (PPARγ) and mammalian target of rapamycin, have been shown to participate in peripheral glucose metabolism [16–19].”
Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2)
DeStefano, M. A., & Jacinto, E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130018 · Cited by 61
Yoon, M.-S., & Choi, C. S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.93 · Cited by 53
Li, T., Weng, J., Zhang, Y., Liang, K., Fu, G., Li, Y., Bai, X.-C., & Gao, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1828-2 · Cited by 43
Phosphoinositides: Key modulators of energy metabolism
Bridges, D., & Saltiel, A. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.008 · Cited by 59
Williamson, D. L., Li, Z., Tuder, R. M., Feinstein, E., Kimball, S. R., & Dungan, C. M. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01350.2013 · Cited by 55
Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing
Bettedi, L., & Foukas, L. C. (2017) · Biogerontology · doi:10.1007/s10522-017-9724-6 · Cited by 53
Li, X., Zhu, Q., Wang, W., Qi, J., He, Y., Wang, Y., Lu, Y., Wu, H., Ding, Y., & Sun, Y. W. (2018) · The FASEB Journal · doi:10.1096/fj.201802829r · Cited by 57
Nutritional Modulation of Insulin Resistance
Weickert, M. O. (2012) · Scientifica · doi:10.6064/2012/424780 · Cited by 53
“[122] S.”
BackgroundContemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)
Olekšák, P., Nepovimová, E., Chrienová, Ž., Musílek, K., Patočka, J., & Kuča, K. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114498 · Cited by 57
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 60
“, mTOR/S6K1 (Um et al., 2004), MAPK (De Fea and Roth, 1997), and PKCz (Lee et al.”
BackgroundInfluentialTalukdar, I., Szeszel-Fedorowicz, W., & Salati, L. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505531200 · Cited by 53
Catalán, V., Gómez‐Ambrosi, J., Rodríguez, A., Ramírez, B., Andrada, P., Rotellar, F., Valentí, V., Moncada, R., Martí, P., Silva, C., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0632-9 · Cited by 59
“Recently, the ribosomal protein S6 kinase 1 (S6K1), a component of the insulin signalling pathway, has been proposed as a key molecular factor in insulin resistance development under conditions of nutrient overload [13–15].”
BackgroundInfluentialYoon, S.-O., Shin, S., Karreth, F. A., Buel, G. R., Jedrychowski, M. P., Plas, D. R., Dedhar, S., Gygi, S. P., Roux, P. P., Dephoure, N., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.033 · Cited by 52
“Inhibition of mTORC1 is also known to decrease insulin receptor substrate (IRS) phosphorylation at serine residues by feedback mechanisms (Um et al., 2004).”
He, G., Sung, Y. M., DiGiovanni, J., & Fischer, S. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3111 · Cited by 55
“On the other hand, mice lacking p70S6K are protected from high-fat diet–induced insulin resistance (44).”
BackgroundLeontieva, O. V., Paszkiewicz, G. M., & Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100528 · Cited by 51
“It is stimulated by nutrients (food), insulin, insulin-like growth factor 1 (IGF-1), testosterone, oxygen, and pro-inflammatory cytokines [39, 55, 62, 114-130].”
BackgroundTuberous sclerosis complex: linking cancer to metabolism
Mieulet, V., & Lamb, R. F. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.05.001 · Cited by 56
mTOR signaling in neural stem cells: from basic biology to disease
Magri, L., & Galli, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1196-x · Cited by 54
mTOR Inhibition: From Aging to Autism and Beyond
Kaeberlein, M. (2013) · Scientifica · doi:10.1155/2013/849186 · Cited by 51
“[198] S.”
BackgroundRapamycin induces transactivation of the EGFR and increases cell survival
Chaturvedi, D., Gao, X., Cohen, M. S., Taunton, J., & Patel, T. B. (2009) · Oncogene · doi:10.1038/onc.2008.490 · Cited by 52
“Thus, rapamycin- induced inhibition of mTOR and, therefore, suppression of p70S6K activity alleviates the “negative feed-back” inhibition of IRS-1 and results in increased IRS-1 protein levels to further activate Akt by augmenting IGF-I receptor signaling.”
BackgroundKodamullil, A. T., Younesi, E., Naz, M., Bagewadi, S., & Hofmann‐Apitius, M. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.02.006 · Cited by 60
“Furthermore, mouse models lacking S6K1 (C57BL/6J) display enhanced insulin sensitivity [7].”
Heřmanová, I., Arruabarrena-Aristorena, A., Vališ, K., Nůsková, H., Alberich-Jordà, M., Fišer, K., Fernández‐Ruiz, S., Kavan, D., Pecinová, A., Niso‐Santano, M., et al. (2015) · Leukemia · doi:10.1038/leu.2015.213 · Cited by 55
Suryawan, A., Escobar, J., Frank, J. W., Nguyen, H. V., & Davis, T. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00069.2006 · Cited by 55
“In skeletal muscle, S6K2 can compensate for some of S6K1 functions (55).”
Background
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.